focus -WSS

focus

author：fashion 2025-09-30 00:35:57 - browse：547

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Florida Supreme Court upholds state's abortion ban

WSS

Overprescribed: High cost isn't America's only drug problem

Diversity in clinical trials starts with building trust, experts say

Cholera vaccine supply gets boost as demand surges globally

More tobacco lobbyists active in statehouses

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Bird flu reported in person exposed to presumably infected cattle

Wikipedia

focus

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Four alarming medical procedures we’re glad history forgot

The cancer drug shortage isn’t new — and neither are the solutions

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Dobbs anniversary: the lost opportunity of abortion as health care

Close Medicare's dangerous gaps in addiction treatment coverage

Wildfire smoke exposes gaps in outdoor worker protections

Multiple sclerosis has subtypes with different best treatments: study

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

People with mental disorders often marry others with same

entertainment

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Bird flu in dairy cattle: New measures to control spread to humans

First Opinion on colorectal cancer screening: letter and response

Cell therapy fails to slow type 1 diabetes, but safety is established

H5N1 bird flu virus started spreading in cows in Texas in December

Why does health care cost so much? A reading guide

focus

focus

focus

Wikipedia